VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, December 2020
A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in December, 2020 for $252,813.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, December 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.